NM_001267550.2:c.18029-19G>C

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001267550.2(TTN):​c.18029-19G>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.203 in 1,555,784 control chromosomes in the GnomAD database, including 38,471 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.23 ( 4869 hom., cov: 33)
Exomes 𝑓: 0.20 ( 33602 hom. )

Consequence

TTN
NM_001267550.2 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:11

Conservation

PhyloP100: 0.145

Publications

12 publications found
Variant links:
Genes affected
TTN (HGNC:12403): (titin) This gene encodes a large abundant protein of striated muscle. The product of this gene is divided into two regions, a N-terminal I-band and a C-terminal A-band. The I-band, which is the elastic part of the molecule, contains two regions of tandem immunoglobulin domains on either side of a PEVK region that is rich in proline, glutamate, valine and lysine. The A-band, which is thought to act as a protein-ruler, contains a mixture of immunoglobulin and fibronectin repeats, and possesses kinase activity. An N-terminal Z-disc region and a C-terminal M-line region bind to the Z-line and M-line of the sarcomere, respectively, so that a single titin molecule spans half the length of a sarcomere. Titin also contains binding sites for muscle associated proteins so it serves as an adhesion template for the assembly of contractile machinery in muscle cells. It has also been identified as a structural protein for chromosomes. Alternative splicing of this gene results in multiple transcript variants. Considerable variability exists in the I-band, the M-line and the Z-disc regions of titin. Variability in the I-band region contributes to the differences in elasticity of different titin isoforms and, therefore, to the differences in elasticity of different muscle types. Mutations in this gene are associated with familial hypertrophic cardiomyopathy 9, and autoantibodies to titin are produced in patients with the autoimmune disease scleroderma. [provided by RefSeq, Feb 2012]
TTN-AS1 (HGNC:44124): (TTN antisense RNA 1) This gene encodes a non-coding RNA transcribed from the opposite strand to the titin gene. [provided by RefSeq, Aug 2016]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.93).
BP6
Variant 2-178730390-C-G is Benign according to our data. Variant chr2-178730390-C-G is described in ClinVar as [Benign]. Clinvar id is 137838.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.633 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TTNNM_001267550.2 linkc.18029-19G>C intron_variant Intron 61 of 362 ENST00000589042.5 NP_001254479.2 A0A0A0MTS7

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TTNENST00000589042.5 linkc.18029-19G>C intron_variant Intron 61 of 362 5 NM_001267550.2 ENSP00000467141.1 A0A0A0MTS7

Frequencies

GnomAD3 genomes
AF:
0.231
AC:
35153
AN:
151870
Hom.:
4859
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.256
Gnomad AMI
AF:
0.502
Gnomad AMR
AF:
0.300
Gnomad ASJ
AF:
0.170
Gnomad EAS
AF:
0.652
Gnomad SAS
AF:
0.255
Gnomad FIN
AF:
0.147
Gnomad MID
AF:
0.133
Gnomad NFE
AF:
0.181
Gnomad OTH
AF:
0.224
GnomAD2 exomes
AF:
0.249
AC:
50529
AN:
203110
AF XY:
0.241
show subpopulations
Gnomad AFR exome
AF:
0.257
Gnomad AMR exome
AF:
0.375
Gnomad ASJ exome
AF:
0.168
Gnomad EAS exome
AF:
0.665
Gnomad FIN exome
AF:
0.147
Gnomad NFE exome
AF:
0.177
Gnomad OTH exome
AF:
0.229
GnomAD4 exome
AF:
0.200
AC:
281234
AN:
1403796
Hom.:
33602
Cov.:
45
AF XY:
0.201
AC XY:
138926
AN XY:
692738
show subpopulations
African (AFR)
AF:
0.261
AC:
8037
AN:
30768
American (AMR)
AF:
0.362
AC:
11808
AN:
32630
Ashkenazi Jewish (ASJ)
AF:
0.164
AC:
3835
AN:
23326
East Asian (EAS)
AF:
0.661
AC:
25653
AN:
38784
South Asian (SAS)
AF:
0.245
AC:
18917
AN:
77248
European-Finnish (FIN)
AF:
0.146
AC:
7562
AN:
51682
Middle Eastern (MID)
AF:
0.221
AC:
1209
AN:
5478
European-Non Finnish (NFE)
AF:
0.177
AC:
191834
AN:
1086220
Other (OTH)
AF:
0.215
AC:
12379
AN:
57660
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.480
Heterozygous variant carriers
0
11169
22338
33507
44676
55845
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
7296
14592
21888
29184
36480
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.232
AC:
35206
AN:
151988
Hom.:
4869
Cov.:
33
AF XY:
0.234
AC XY:
17395
AN XY:
74272
show subpopulations
African (AFR)
AF:
0.256
AC:
10607
AN:
41452
American (AMR)
AF:
0.300
AC:
4582
AN:
15254
Ashkenazi Jewish (ASJ)
AF:
0.170
AC:
590
AN:
3470
East Asian (EAS)
AF:
0.651
AC:
3359
AN:
5158
South Asian (SAS)
AF:
0.255
AC:
1223
AN:
4804
European-Finnish (FIN)
AF:
0.147
AC:
1558
AN:
10580
Middle Eastern (MID)
AF:
0.146
AC:
43
AN:
294
European-Non Finnish (NFE)
AF:
0.181
AC:
12308
AN:
67956
Other (OTH)
AF:
0.227
AC:
478
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1358
2717
4075
5434
6792
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
360
720
1080
1440
1800
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.187
Hom.:
568
Bravo
AF:
0.251
Asia WGS
AF:
0.431
AC:
1500
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:11
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:5
Aug 16, 2019
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Clinical Genetics, Academic Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Oct 31, 2012
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Autosomal recessive limb-girdle muscular dystrophy type 2J Benign:1
Sep 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Autosomal recessive limb-girdle muscular dystrophy type 2J;C1858763:Dilated cardiomyopathy 1G Benign:1
Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Early-onset myopathy with fatal cardiomyopathy Benign:1
Sep 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Tibial muscular dystrophy Benign:1
Sep 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Myopathy, myofibrillar, 9, with early respiratory failure Benign:1
Sep 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.93
CADD
Benign
4.1
DANN
Benign
0.49
PhyloP100
0.14
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs17076; hg19: chr2-179595117; COSMIC: COSV60101809; COSMIC: COSV60101809; API